Amgen launches an AbbVie Humira biosimilar in the U.S.
By Sam Boughedda After a dip earlier in the session, AbbVie (NYSE:ABBV) shares are now slightly up on the day, holding steady, despite Amgen (NASDAQ:AMGN) announcing AMJEVITA, a biosimilar...
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| Standard Bank | 9,143 | 9,170 | 9,100 | +52 | +0.57% | 12.28K | |||
| Investec | 11,063 | 11,152 | 11,000 | -2 | -0.02% | 1.20M | |||
| Kaap Agri Bedryf | 4,150 | 4,182 | 4,125 | 0 | 0.00% | 79.61K | |||
| Frontier Transport Holdings | 475 | 544 | 468 | +8 | +1.71% | 3.56K | |||
| Thungela Resources | 22,694.00 | 23,185.00 | 21,902.00 | +612.00 | +2.71% | 1.73M | |||
| Investec Pref | 9,400 | 9,410 | 9,400 | -10 | -0.11% | 4.44K | |||
| Astral | 16,117 | 16,201 | 15,790 | +214 | +1.35% | 125.51K | |||
| Caxton | 890 | 890 | 882 | 0 | 0.00% | 103.59K | |||
| PSG | 2,295 | 2,295 | 2,288 | +0 | +0.00% | 0 | |||
| Distell | 17,450 | 17,533 | 17,425 | +15 | +0.09% | 231.51K |
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| Gold Fields ADR | 11.400 | 11.480 | 11.290 | -0.220 | -1.89% | 2.68M | |||
| Harmony Gold Mining | 3.525 | 3.530 | 3.471 | +0.005 | +0.14% | 2.34M | |||
| AngloGold Ashanti ADR | 20.75 | 21.07 | 20.53 | -0.37 | -1.73% | 2.46M | |||
| Sibanye Gold ADR | 10.68 | 10.70 | 10.44 | 0.00 | 0.00% | 1.87M | |||
| DRDGOLD ADR | 8.10 | 8.22 | 7.89 | +0.19 | +2.47% | 121.59K |
|
|
|
Name
|
Last
|
High
|
Low
|
Chg
|
Chg%
|
Volume
|
Time
|
|---|---|---|---|---|---|---|---|---|---|
| Tesla | 171.76 | 173.75 | 162.78 | +5.10 | +3.06% | 151.71M | |||
| Apple | 143.71 | 143.91 | 142.28 | +0.70 | +0.49% | 31.10M | |||
| Meta Platforms | 148.86 | 149.88 | 147.52 | +1.80 | +1.22% | 19.49M | |||
| General Motors | 39.10 | 39.73 | 38.33 | +2.81 | +7.74% | 34.76M | |||
| Microsoft | 246.69 | 247.02 | 242.95 | +3.98 | +1.64% | 10.57M |
Equities News & Analysis
-
-
Generac introduces new EV charging system
By Michael Elkins Energy technology design company, Generac Holdings Inc (NYSE:GNRC) announced today the introduction of its first electric vehicle charging system. The 48A / 11.5kW...
-
Midday movers: General Motors, McDonald's, Pfizer and more
By Liz Moyer Investing.com -- Stocks were moving higher as tech stocks led the gains, aiming to close out January on a high note. Here are the midday movers for Jan. 31. General Motors...
-
Elon Musk seeks to end lawsuit over 'inadvertent' late disclosure of Twitter stake
By Jonathan Stempel NEW YORK (Reuters) - Elon Musk asked a U.S. judge to throw out a lawsuit claiming that his delayed disclosure of a large stake in Twitter Inc defrauded shareholders who...
-
Alphabet a more defensive stock in 2023 - BofA
By Sam Boughedda Ahead of Alphabet's (NASDAQ:GOOGL) earnings release on Thursday, February 2, BofA analysts raised the firm's price target on the stock to $119 from $116, maintaining a Buy...
-
Are Consumer Stocks Sending Chills to Broader Market?
For nearly 15 years, consumer stocks moved higher in an orderly trend. But more recently, that trend has changed from bullish to uncertain.And we can see this in today’s ratio chart.Above is...
-
FleetCor seen benefiting from 2022 deals and freight turnaround
By Liz Moyer Investing.com -- FleetCor Technologies Inc (NYSE:FLT), a maker of digital payments solutions software for businesses, will benefit from its customer acquisition activity in 2022...
-
Tesla considering plant near Mexico City's new airport, Mexican official says
By Diego Oré MEXICO CITY (Reuters) - Electric carmaker Tesla (NASDAQ:TSLA) Inc is considering setting up an assembly plant near a new Mexico City airport, which would serve as an export hub...
-
U.S. Justice Department seeks Tesla driver-assist documents
By Akash Sriram and David Shepardson WASHINGTON (Reuters) - Tesla (NASDAQ:TSLA) Inc disclosed on Tuesday the U.S. Justice Department has sought documents related to its Full Self-Driving...
-
Edwards Lifesciences cut to underperform at Bernstein as organic growth slows
By Sam Boughedda Bernstein analysts double downgraded Edwards Lifesciences (NYSE:EW) to Underperform from Outperform on Tuesday, cutting the firm's price target on the stock to $66 from $95...
